Results 11 to 20 of about 5,153,703 (360)
Thyroid, 2021 Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer. Since the guidelines for the management of ATC by the American Thyroid Association were first published in 2012, significant clinical and scientific advances ...
K. Bible +18 more
semanticscholar +1 more source
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.
Diabetes Care, 2022 OBJECTIVE To determine whether use of glucagon-like peptide 1 (GLP-1) receptor agonists (RA) is associated with increased risk of thyroid cancer. RESEARCH DESIGN AND METHODS A nested case-control analysis was performed with use of the French national ...
J. Bezin +7 more
semanticscholar +1 more source
Evaluation of Gender Inequity in Thyroid Cancer Diagnosis
JAMA Internal Medicine, 2021 Key Points Question How does thyroid cancer risk vary by sex? Findings The cohort study in this comparison study found that the current ratio of small (≤2 cm) papillary thyroid cancer (PTC) incidence in women to men is 4.39:1, and the meta-analysis found
Karissa L LeClair +5 more
semanticscholar +1 more source
Theranostics, 2022 Background: Cancer stem cells (CSCs) are highly tumorigenic, chemotherapy-resistant, tumor growth-sustaining, and are implicated in tumor recurrence. Previous studies have shown that lysine-specific histone demethylase 1A (KDM1A) is highly expressed in ...
Wei Zhang +12 more
semanticscholar +1 more source
Associations between artificial light at night and risk for thyroid cancer: A large US cohort study
Cancer, 2021 Light at night (LAN) inhibits nighttime secretion of melatonin and may cause circadian disruption, which may be a risk factor for cancer. Recent studies have linked high LAN exposure with elevated breast cancer risk.
Dong Zhang +4 more
semanticscholar +1 more source
Thyroid cancer, recent advances in diagnosis and therapy
International Journal of Cancer, 2021 Over the past several decades, the approach to the diagnosis and management of patients with follicular cell‐derived thyroid cancer has evolved based on improved classification of patients better matching clinical outcomes, as well as advances in imaging,
F. Nabhan, Priya H. Dedhia, M. Ringel
semanticscholar +1 more source
Characterizing dedifferentiation of thyroid cancer by integrated analysis
Science Advances, 2021 Clinical staining and targeting CREB3L1 facilitates precise stratification and a potential treatment strategy for thyroid cancer. Understanding of dedifferentiation, an indicator of poo prognosis for patients with thyroid cancer, has been hampered by ...
Han Luo +30 more
semanticscholar +1 more source
Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study
Thyroid, 2021 Background: Current guidelines recommend against thyrotropin (TSH) suppression in low-risk differentiated thyroid cancer patients; however, physician practices remain underexplored.
Maria Papaleontiou +6 more
semanticscholar +1 more source
Cancer Cell International, 2022 Background Although the prognosis for most patients with papillary thyroid cancer (PTC) is good, the present treatment is ineffective for 5–10% patients.
Yan Wang +10 more
semanticscholar +1 more source
Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma
Frontiers in Endocrinology, 2022 ObjectivesOur aim was to describe our experience in using apatinib as treatment for radioiodine-refractory differentiated thyroid carcinoma (RAIR-DTC).MethodsForty-seven patients undergoing apatinib treatment for RAIR-DTC were prospectively enrolled in ...
Wei Du +4 more
doaj +1 more source